astragaloside a has been researched along with Iron Overload in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W; Liu, L; Xie, D; Xie, H; Zhang, L; Zhou, P | 1 |
| Duan, J; Han, X; Song, Q; Yang, Y; Zhao, Y | 1 |
2 other study(ies) available for astragaloside a and Iron Overload
| Article | Year |
|---|---|
Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload.
Topics: Autophagosomes; bcl-2-Associated X Protein; Cell Line; Cell Survival; Hepatocytes; Humans; Iron Overload; Iron-Dextran Complex; Liver; Microtubule-Associated Proteins; Proto-Oncogene Proteins c-bcl-2; RNA-Binding Proteins; Saponins; Triterpenes | 2019 |
Astragaloside IV protects against retinal iron overload toxicity through iron regulation and the inhibition of MAPKs and NF-κB activation.
Topics: Animals; Humans; Iron; Iron Overload; Male; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Retinal Pigment Epithelium; Saponins; Triterpenes | 2021 |